Navigation Links
AAIPharma Appoints Senior Director of Biopharmaceutical Development
Date:12/7/2012

WILMINGTON, N.C., Dec. 7, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company's senior director of biopharmaceutical development for its Wilmington, N.C. laboratory.

(Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO)

"Tim's focus on customer service and high-quality deliverables makes him a perfect fit for our organization" said Paul Maffuid, executive vice president of AAIPharma's laboratory operations. "His demonstrated leadership within the CMC analytical sector complements our service offerings and will capitalize on the recent biopharmaceutical advancements made within our Wilmington Technology Center."

Dr. Rhines joins AAIPharma with more than 22 years of experience in laboratory management, most recently with Covance Laboratories as the director of chemistry, manufacturing, and controls (CMC) pharmaceutical development services for North America.

"AAIPharma offers exceptional services and a broad expertise in the field of biopharmaceutical services.  Our vision is to continue the growth within AAIPharma's biopharmaceutical development team" Dr. Rhines said.  "AAIPharma's staff of experienced and talented scientists, coupled with recently added state of the art instrumentation within its Technology Center, will continue to establish AAIPharma as an industry leader for biopharmaceutical development and characterization."

Dr. Rhines earned his undergraduate degree in chemistry from the University of Northern Iowa, and a doctorate in analytical chemistry from the University of Iowa.  In addition, Dr. Rhines is a member of the Regulatory Affairs Professional Society, the American Association of Pharmaceutical Sciences and is a past participant in the Midwest United States Pharmacopeia Discussion Group.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit www.aaipharma.com.

 


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Director Of Analytical Chemistry
2. uniQure Appoints Hans Christian Rohde Chief Commercial Officer
3. CIVCO Medical Solutions Appoints Senior Vice President and General Managers to Business Units
4. Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
5. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
6. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
7. Positron Appoints Charles Conroy As Chief Operating Officer
8. Tris Pharma Appoints New Vice President of Business Development
9. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
10. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
11. Discovery Labs Appoints John R. Leone to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , May 2, 2016  While nearly three-quarters of ... can have on their health, only about half report ... to the results of a new survey announced today ... the start of National Osteoporosis Month, Hologic is raising ... affects nearly 56 million Americans. Osteoporosis is ...
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:4/29/2016)... , April 29, 2016 ... life science laboratory due to the growing demands for ... advance technology, contemporary automated systems are already adept of ... by slow, tedious and manual labor. Instrumentation continues to ... not even conceivable just a few years ago. Originally ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... ... – a web application that helps people assess their risk of developing Alzheimer’s ... app will provide users a “Risk Reduction Score™” that summarizes how their lifestyle ...
(Date:5/3/2016)... Baltimore, Md. (PRWEB) , ... May 03, 2016 , ... ... devastating consequences of inappropriate or excessive levels of alcohol use. Alcohol and its ... fetal alcohol spectrum disorders to the susceptibility to strokes in those 65 years and ...
(Date:5/3/2016)... ... May 03, 2016 , ... SELEX (systematic evolution of ... a random library of sequences depending on their attraction for a target molecule. ... selection is commonly performed using filters, panning, or affinity chromatography separations. However, these ...
(Date:5/3/2016)... Chicago (PRWEB) , ... May 03, 2016 , ... ... has hired award-winning creative director Joe Ferrazano to serve in the newly created ... Ferrazano will be overseeing the agency’s creative efforts in the Chicago and LA ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Elizabeth Murray ... pet parrots to join her with one on her shoulder and one on her ... a parking lot because of years of mitral valve prolapse. , The valves of ...
Breaking Medicine News(10 mins):